C Partners Holding’s Biogen BIIB Stock Holding History

C Partners Holding’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-352	Closed	-$124K	–	49
2018 Q3	$124K	Sell	352 -445	-56%	-$153K	0.04%	111
2018 Q2	$231K	Buy	797 +157	+25%	+$44.1K	0.09%	118
2018 Q1	$175K	Sell	640 -203	-24%	-$63K	0.07%	253
2017 Q4	$269K	Buy	+843	New	+$270K	0.11%	150
2015 Q3	–	Sell	-3,600	Closed	-$1.45M	–	20
2015 Q2	$1.45M	Hold	3,600	–	–	0.68%	31
2015 Q1	$1.52M	Sell	3,600 -1,500	-29%	-$591K	0.49%	38
2014 Q4	$1.73M	Buy	+5,100	New	+$1.65M	0.56%	32

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

C Partners Holding's BIIB Position: Q4 2018 in Review

C Partners Holding sold out of Biogen (BIIB) in Q4 2018, closing a stake of 352 shares — an estimated $124K sold.

C Partners Holding first reported a position in BIIB in Q4 2014 and held it in 7 quarters. The position peaked at $1.73M in Q4 2014. 1,141 funds tracked by Wall St. Rank hold BIIB as of Q4 2018.

C Partners Holding reported no remaining Biogen position as of Q4 2018 after selling out during the quarter.
C Partners Holding sold 352 Biogen shares in Q4 2018, an estimated $124K.
C Partners Holding first reported a position in Biogen in Q4 2014 and held it in 7 quarters.
C Partners Holding's Biogen position peaked at $1.73M in Q4 2014.
1,141 funds tracked by Wall St. Rank held Biogen as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.